Beilu Pharma
3000167.612.69% ( -0.21 )
Beilu Pharma (300016)
Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. It provides contrast agen...
- Open
- 7.83
- High
- 7.90
- Low
- 7.56
- Prev. Close
- 7.82
- Volume
- 179.79K
- Turnover
- 138.52M
- Avg Price
- 7.70
- Bid/Ask Ratio
- --
- Amplitude
- 4.35%
- 52wk High
- 11.98
- Volume Ratio
- 0.72
- Turnover Ratio
- 3.19%
Beilu Pharma Analyst Rating
View MoreForecast & Rating
Mar 20, 2021Price forecast
--100.00%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- 同壁财经 · Jun 2 at 03:20 AM
Haichang Pharmaceutical: Termination of the Joint Action Agreement
- Wallstreetcn · Mar 19 at 01:30 AM
The A-share innovative drug concept fluctuated and declined, with SDKX falling over 10%. INNOSTAR, HITECK, Aidea Pharma, Chemexpress, and Beilu Pharma had significant declines
- Wallstreetcn · Mar 5 at 08:40 PM
The three major A-share indices turned positive collectively, innovative drugs rebounded, the Hang Seng Index rose nearly 3%, JD.com increased by over 7%, while crude oil and the shipping index plummeted
- Zhitong · Oct 28, 2025 at 09:59 AM
Beilu Pharma released its performance for the first three quarters, with a net profit attributable to the parent company of 44.1769 million yuan, an increase of 81.10%
- Zhitong · Sep 26, 2025 at 06:15 AM
Beilu Pharma plans to raise no more than 300 million yuan through a simplified procedure for a private placement
- Zhitong · Sep 2, 2025 at 02:47 AM
Beilu Pharma: Haichang Pharmaceutical has obtained GMP certification from the Brazilian National Health Surveillance Agency
